Intelligent Antibiotics for an evolving threat
The rise of multidrug resistant superbacteria has rendered many antimicrobials useless while millions die. We discover synergies between approved drugs and create next generation therapies.
Methicillin-resistant Staphylococcus aureus (MRSA) kills thousands of patients every year. MRSA skin infections can quickly become bloodstream infections. 1 in 8 septic MRSA patients loses their life to this evolving threat. Viosera is developing a therapy that could save these lives.